An evaluation of the in vitro activity of piperacillin/tazobactam

Pathology

Volumn 28, Issue 2, 1996, Pages 167-172

  Daley, D ^a   Mulgrave, L ^b   Munro, R ^a   Neville, S ^a   Smith, H ^c   Dimech, W ^c  

^a LIVERPOOL HOSPITAL   (Australia)

^b Div of Microbiol and Infect Dis   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Piperacillin; Staphylococci; Tazobactam

Indexed keywords

AGAR; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN;

ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ARTICLE; ASPIRATION PNEUMONIA; BACTEROIDES; BACTEROIDES FRAGILIS; CONTROLLED STUDY; DILUTION; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0030431186     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029600169813     Document Type: Article

References (18)

1. Roy C, Fox A, Segura C et al. Plasmid determined beta-lactamases identified in a group of 204 ampicillin-resistant Enterobacteriaceae. J Antimierob Chemother 1983; 12: 507-10.
2. Aymes SGB. Plasmid-mediated beta-lactamases: relative clinical importance. In: Livermore DM, editor. Beta-lactamases: current perspectives. Winchester: Theracom, 1988; 31-48.
3. Sanders CC, Sanders WE. Beta-lactam resistance in Gram negative bacteria: global trends and clinical impact. Clin Infect Dis 1992; 15: 824-39.
4. Knothe H, Shah P, Krcmery V et al. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 315-7.
5. Sanders CC, Iaconis JP, Bodey GP et al. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests. Antimicrob Agents Chemother 1988; 32: 1365-9.
6. Thomson KS, Weber DA, Sanders CC et al. Beta lactamase production in members of the family Enterobacteriacae and resistance to beta-lactam-enzyme inhibitor combinations. Antimicrob Agents Chemother 1990; 34: 622-7.
7. Wiedemann B. Genetic and biochemical basis of resistance of Enterobacteriaceae to beta-lactam antibiotics. J Antimicrob Chemother 1986; 18 Suppl B: 31-8.
8. Sanders WE Jr, Sanders CC. Inducible beta-lactamases: clinical and epidemiological implications for use of newer cephalosporins. Rev Infect Dis 1988; 10: 830-8.
9. Gutman L, Kitzis M-D, Yamabe S et al. Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harbouring known beta-lactamases. Antimicrob Agents Chemother 1986; 29: 955-7.
10. Eliopoulos GM, Klimm K, Ferraro MJ et al. Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830). Diagn Microbiol Infect Dis 1989; 12: 481-8.
11. Fass RJ, Prior RB. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate. Antimicrob Agents Chemother 1989; 33: 1268-74.
12. Appelbaum PC, Jacobs MR, Spangler SK et al. Comparative activity of beta-lactamase inhibitor YTR 830, clavulanate and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes. Antimicrob Agents Chemother 1986; 30: 789-91.
13. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989; 27: 731-43.
14. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically M7-A3. NCCLS, Villanova, PA, 1993.
15. National Committee for Clinical Laboratory Standards: Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria M11-A3. NCCLS, Villanova, PA, 1983.
16. Turnidge J, Lawson P, Munro R et al. A national survey of antibiotic resistance in Staphylococcus aureus in Australian hospitals. Med J Aust 1989; 150: 65-72.
17. Jorgensen JH, McElmeel ML, Maher LA. Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae using the E test. J Clin Microbiol 1991; 29: 109-14.
18. Seetulsingh P, Hall LMC, Livermore DM. Activity of clavulanate combinations against TEM-1 beta-lactamase producing Escherichia coli isolates obtained in 1982 and 1989. J Antimicrob Chemother 1991; 27: 749-59.